Skip to main content
. 2023 Dec 6;9(4):e003476. doi: 10.1136/rmdopen-2023-003476

Table 4.

Multivariable analysis of associations with significant fatigue

Parameters Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Female 2.10 (0.69 to 6.43) 0.26
Self-reported active SLE 4.55 (2.63 to 7.89) <0.0001* 2.26 (1.17 to 4.40) 0.02*
Clinically significant pain 5.68 (3.26 to 9.90) <0.0001* 2.83 (1.44 to 5.54) 0.002*
Positive score FiRST 4.87 (2.67 to 8.85) <0.0001* 2.50 (1.26 to 4.96) 0.008*
Clinical anxiety 2.24 (1.27 to 3.96) 0.006* 0.94 (0.46 to 1.93) 0.88
Clinical depression 4.14 (1.75 to 9.80) 0.0003* 1.92 (0.74 to 4.99) 0.18
Clinical insomnia 4.46 (2.45 to 8.11) <0.0001* 3.31 (1.73 to 4.34) 0.0003*
High level of stress 3.71 (2.15 to 6.41) <0.0001* 1.97 (1.01 to 3.83) 0.045*
Low level of physical activity 1.42 (0.81 to 2.48) 0.27

*P value<0.05; R² for multivariable model: 0.23.

FiRST, Fibromyalgia Rapid Screening Tool; SLE, systemic lupus erythematosus.